GSK PLC (NYSE:GSK) Stock News, Headlines & Updates
GSK PLC Stock News from GuruFocus
- 1
Jun 07, 2024
US FDA Approves Expanded Age Indication for GSK's AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
Business Wire • 6:00pm
Jun 03, 2024
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
Business Wire • 8:00am
Jun 02, 2024
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
Business Wire • 10:00am
May 15, 2024
GSK PLC's Dividend Analysis
GuruFocus Research • 5:02am
May 07, 2024
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Marketwired • 12:00am
May 02, 2024
Q1 2024 GSK plc Earnings Call Transcript
GuruFocus Research • 10:09am
Q1 2024 GSK plc Earnings Call Transcript
GuruFocus Research • 11:13pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news